WYETH LIMITED

Wyeth Limited is a subsidiary of Wyeth, USA; a global leader in pharmaceuticals, consumer healthcare and animal health products.

Wyeth Limited was incorporated on September 20, 1947 as a private limited company under the name Lederle Laboratories (India) Ltd. The name was changed to Cyanamid India Limited on October 31, 1962. The company became a public enterprise in November 1965.

Three companies - Wyeth Laboratories Limited, John Wyeth (India) Limited and Wyeth (India) Private Limited - were amalgamated with Cyanamid India Limited and the combined entity was named Wyeth Lederle Limited on January 1, 1998.

Effective April 1, 2003, Geoffrey Manners & Co. Limited was merged with Wyeth Lederle Limited and the name of the company was changed to Wyeth Limited.

Wyeth Limited is a market leader in oral contraceptives, folic acid and depilatory cream.

Wyeth pioneered the introduction of several new therapies in India. Wyeth was the first to launch hormone therapy. In the field of vaccines, Wyeth introduced vaccines against HIB and invasive pneumococcal disease in the country.

Enbrel, a breakthrough treatment for rheumatoid arthritis and Rapamune, an immuno suppressant for prevention of rejection after renal transplant, Prevenar, a pneumococcal conjugate vaccine and Tygacil, the world's first glycilcycline antibiotic, are among internationally known products launched by Wyeth Limited in India.

Wyeth Limited is among India's leading multinational companies. The company has a state-of-the-art manufacturing facility in Goa.

Back